Polaris Market Research presents its latest market research report, titled Point of Care (PoC) Diagnostics Market. It is a comprehensive market research report analyzing the fast-evolving point of care (PoC) diagnostics market. The report offers insight into the current market landscape, drivers for growth, emerging trends, competitive dynamics, and future scope for growth. The study combines qualitative and quantitative analysis, giving insights about the size of the market, segments, regional performance, and industry developments. By going through the report, stakeholders can get an in-depth overview of the point of care (PoC) diagnostics market and its outlook during the forecast period.

point of care (PoC) diagnostics Market Key Takeaways

• The point of care (PoC) diagnostics market size was valued at USD 60.99 billion in 2025.
• The market is estimated to reach USD 136.90 billion by 2034.
• The market is projected to witness a CAGR of 9.40% from 2026 to 2034.
• The infectious diseases segment held roughly 33.3% of the market share in 2025.
• The OTC (mode of prescription) segment is likely to grow at a 9.9% CAGR during the forecast period.
• The North America region held 42.6% of market share in 2025.
• The Asia Pacific region is expected to grow at a 10.1% CAGR from 2026 to 2034.

What is the point of care (PoC) diagnostics Market?

Point-of-care diagnostics refers to medical testing performed at or near the site of patient care, giving clinicians immediate access to results that support timely treatment decisions. Rather than waiting on centralized laboratory turnaround, providers can use compact analyzers, rapid test kits, and connected biosensors to evaluate conditions such as infections, glucose levels, and cardiac markers within minutes. This immediacy is especially valuable in emergency departments, primary care clinics, and home settings where fast answers directly influence patient outcomes.

Market Dynamics

The report examines the key market dynamics influencing the growth and development of the point of care (PoC) diagnostics market. It analyzes the market drivers, market opportunities, market trends, and restraints that might impact the growth of the market.

Key Market Driver: Growing Prevalence of Chronic and Infectious Diseases

Rising rates of chronic conditions such as diabetes and cardiovascular disease, alongside a steady burden of infectious illness, are pushing healthcare systems toward testing that can be performed at the patient's location. Point-of-care platforms cut the time between sample collection and actionable results, helping clinicians start treatment sooner and manage disease progression more effectively, which in turn is reinforcing demand across both hospital and community care settings.

Market Opportunity: Expansion into Decentralized Care Settings

Pharmacies, home-care environments, and other decentralized settings are opening new avenues for point-of-care adoption as patients increasingly seek convenient, self-managed testing options. Vendors that design intuitive, affordable devices for glucose monitoring, pregnancy testing, and similar applications stand to capture this shift toward consumer-driven diagnostics outside traditional clinical walls.

𝐁𝐫𝐨𝐰𝐬𝐞 𝐌𝐨𝐫𝐞 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬:

https://www.polarismarketresearch.com/industry-analysis/point-of-care-poc-diagnostics-market 

Emerging Market Trend: AI-Enabled Diagnostic Interpretation

Artificial intelligence is increasingly embedded into point-of-care devices to interpret complex data patterns, flag abnormal results, and reduce human error. Beyond result interpretation, AI is streamlining workflows such as inventory management and automatic upload of results into electronic health records, freeing clinical staff from administrative burden while improving consistency across testing sites.

Market Challenge: Complex Regulatory Approval Pathways

Bringing new point-of-care devices to market often means navigating lengthy and varied regulatory review processes across different jurisdictions. These requirements can delay product launches and add to overall development costs, creating a hurdle for smaller manufacturers and slowing the pace at which innovative diagnostic tools reach patients.

How Is Market Segmentation Done?

The research gives an in-depth segmental analysis of the point of care (PoC) diagnostics industry. The segmentation in the market has been done on the basis of product, mode of prescription, and end use. This research assesses the contribution of each segment and pinpoints the segments driving the present-day demand and those that will grow strongly during the forecast period. This analysis helps stakeholders analyze evolving demand trends and recognize promising market opportunities.

Which Region Leads Market Demand?

The report includes a regional analysis of the point of care (PoC) diagnostics market, covering North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North America market dominates the overall market, attributed to its technologically advanced healthcare infrastructure and wide availability of diagnostic devices across hospitals, clinics, and home-care settings. Further, the Asia Pacific market is expected to witness significant growth during the forecast period, influenced by improving healthcare facilities and rising demand for cost-effective testing solutions across the region. In addition to this, there is an analysis of regional demand, investments, infrastructure, regulatory environment, technology penetration, and industry development.

Who Are the Key Market Players?

The report presents a detailed competitive analysis of the point of care (PoC) diagnostics industry. Player positioning and strategy, such as new product/service launches, partnerships, mergers and acquisitions, geographic expansion, capacity expansion, and technological developments, have been analyzed. The report also examines the competitive structure of the industry and how organizations are responding to changing consumer demands.

A few of the key players in the market include:

• Abbott
• BD
• bioMérieux
• Danaher Corporation
• EKF Diagnostics Holdings plc
• F. Hoffmann-La Roche Ltd
• Quest Diagnostics Incorporated
• QuidelOrtho Corporation
• Siemens Healthcare Private Limited
• Thermo Fisher Scientific Inc.

Future Outlook

The point of care diagnostics market is projected to keep evolving through 2034 as artificial intelligence, wearable diagnostics, and home-based self-testing gain wider acceptance. Decentralized healthcare models are likely to expand further into underserved and remote regions, supported by continued progress in biosensor design, connectivity, and molecular testing. Growing attention to preventive care and real-time health monitoring is expected to remain a key driver of the market's development.

More Trending Latest Reports By Polaris Market Research:

mens-jewelry-market

offshore-support-vessel-market

car-t-cell-therapy-market

top-maleic-anhydride-manufacturers-and-key-insights-2024

top-10-electric-bike-sharing-services-companies-in-2025:-future-of-e-bikes-sharing

polyvinyl-chloride-pvc-market

cannabidiol-market

smart-home-energy-monitoring-devices-market

dental-loupe-market